© 2021 MJH Life Sciences™ and Urology Times. All rights reserved.
By risk-stratifying nonmuscle-invasive bladder cancers, urologists can characterize pathologic subtypes and develop individualized treatment and surveillance strategies.(CME)
Related Content:
News